Metsera (MTSR) says in a Delaware court filing that it will accept superior bids until closing and states that Pfizer (PFE) drops its demand that Metsera denounce the Novo Nordisk (NVO) bid, according to Bloomberg.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTSR:
- Metsera falls after FTC raises filing concerns over Novo bid
- FTC says Novo bid for Metsera raises filing concerns, Bloomberg reports
- Metsera drops 5% to $69.55 after Bloomberg report of FTC filing concerns
- M&A News: Novo Nordisk Stock (NVO) Slides after Increasing Its Metsera Offer to $10B
- Midday Fly By: Palantir reports Q3 beat, Starbucks forms China JV